| Sep 16 |
Calliditas Therapeutics to be delisted from Nasdaq Stockholm
|
| Sep 16 |
Delisting of Calliditas Therapeutics AB (publ) from Nasdaq Stockholm
|
| Sep 6 |
Travere Stock Pops After Snagging Full Approval For Calliditas Rival In Kidney Disease
|
| Sep 3 |
Notice of extraordinary meeting of Calliditas Therapeutics AB (publ)
|
| Sep 3 |
Calliditas Therapeutics takes certain corporate actions following announcement by Asahi Kasei
|
| Aug 14 |
3 Swedish Growth Companies With Up To 30% Insider Ownership
|
| Aug 13 |
Calliditas Therapeutics AB (publ) (CALT) Q2 2024 Earnings Call Transcript
|
| Aug 13 |
Calliditas Therapeutics GAAP EPS of -SEK 5.47, revenue of SEK 855.3M
|
| Aug 13 |
Calliditas Therapeutics GAAP EPS of -SEK 0.88, revenue of SEK 559.8M
|
| Aug 13 |
Calliditas Interim Report January to June 2024
|
